Skip to main content
Clinical Trials/NCT06238999
NCT06238999
Active, not recruiting
Not Applicable

Clinical Evaluation of a New Flowable Composite for Direct Restorative Treatment of Non-carious Cervical Lesions: A Prospective Randomized Split-mouth Study

Ivoclar Vivadent AG1 site in 1 country66 target enrollmentFebruary 20, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Non-carious Cervical Lesions
Sponsor
Ivoclar Vivadent AG
Enrollment
66
Locations
1
Primary Endpoint
Postoperative Hypersensitivity
Status
Active, not recruiting
Last Updated
6 months ago

Overview

Brief Summary

The overall objective of this clinical investigation is to evaluate the clinical safety and performance of the new flowable composite TM Flow for treatment of non-carious cervical lesions. Each participant receives two different fillings (test- and control material) in two different teeth. The fillings are assessed according to selected FDI criteria at baseline (7-10 days after filling placement) and after 1, 6, 12, 24, 36 and 60 months.

Registry
clinicaltrials.gov
Start Date
February 20, 2024
End Date
December 31, 2029
Last Updated
6 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Informed Consent signed by the subject
  • Age: 18-65 years
  • 2 NCCL needing treatment, comparable in extend and size, preferably located in different quadrants
  • Vital teeth, regular sensitivity
  • Sufficient language skills
  • No active periodontitis
  • Preoperative VAS values \< 3 regarding tooth sensitivity on biting. Tooth sensitivity on temperature or touching (tooth brushing, probing) originating in the area of the NCCL is accepted.
  • Subject wishes to have a restoration as part of the study (written declaration of consent after detailed explanation)

Exclusion Criteria

  • Not completed hygiene phase or poor oral hygiene
  • Sufficient isolation of the cavity not possible
  • Patients with a proven allergy to one of the ingredients (methacrylates)
  • Patients with severe systemic diseases
  • Periodontally insufficient dentition
  • Pregnancy
  • Part of the development project team of TM Flow
  • Staff of the study management team
  • Staff of the internal clinic

Outcomes

Primary Outcomes

Postoperative Hypersensitivity

Time Frame: 1 month

assessed by tests with thermal stimuli and occlusal forces (during biting) determined by VAS (Visual Analog Scale, 0 "No pain at all" - 10 "The worst pain imaginable") following the FDI criteria on a scale from 1 "very good" to 5 "unacceptable" FDI 1: no complaint FDI 2: minor complaint FDI 3: distinct pain FDI 4: persistent pain for prolonged period of time FDI 5: treatment unavoidable

Secondary Outcomes

  • Evaluation of Functional (e.g. Fracture of the Material and Retention), Biological (e.g. Caries at Restoration Margins) and Aesthetic (e.g. Color Match) Properties of the Restorations(5 years)

Study Sites (1)

Loading locations...

Similar Trials